LFF
NVAX icon

Level Four Financial’s Novavax NVAX Stock Holding History

Level Four Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$249K Buy
+1,200
New +$264K 0.11% 233

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Level Four Financial's NVAX Position: Q3 2021 in Review

Level Four Financial opened a new position in Novavax (NVAX) in Q3 2021: 1,200 shares worth $249K. The stake represents 0.11% of the portfolio and ranks #233 among its holdings.

443 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

  • Level Four Financial held 1,200 shares of Novavax worth $249K as of Q3 2021.
  • Novavax was a new Level Four Financial position in Q3 2021.
  • Novavax made up 0.11% of Level Four Financial's portfolio in Q3 2021, its #233 holding.
  • 443 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on Level Four Financial's 13F filing for Q3 2021, filed 12 Oct 2021.